INS and type 2 diabetes mellitus: In addition, within the context of obesity-associated IR, BITC enhanced insulin sensitivity in a Nrf2-dependent manner, lowering hyperglycemia in vivo and in vitro and potentially protecting against obesity-related T2D [89].